Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-04-13

Clinical Trial Update: Pharmacokinetics of Mefloquine-Artesunate in Pregnant Women With Uncomplicated Plasmodium Falciparum Infection [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial investigating the pharmacokinetics of the mefloquine-artesunate combination in pregnant women with uncomplicated Plasmodium falciparum malaria ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artesunate (artesunate)
  • Mefloquine (Mefloquine)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Malaria, Pregnancy | Phase 2, Phase 3 | Status: WITHDRAWN